Viridian Therapeutics
VRDN
VRDN
136 hedge funds and large institutions have $1.24B invested in Viridian Therapeutics in 2024 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 62 increasing their positions, 36 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
6% less capital invested
Capital invested by funds: $1.32B → $1.24B (-$77.5M)
50% less funds holding in top 10
Funds holding in top 10: 10 → 5 (-5)
54% less call options, than puts
Call options by funds: $2.88M | Put options by funds: $6.23M
Holders
136
Holding in Top 10
5
Calls
$2.88M
Puts
$6.23M
Top Buyers
| 1 | +$33.7M | |
| 2 | +$31.3M | |
| 3 | +$31.2M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$23.4M |
| 5 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$19.3M |
Top Sellers
| 1 | -$21.8M | |
| 2 | -$11.8M | |
| 3 | -$8.53M | |
| 4 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
-$8.3M |
| 5 |
B
Braidwell
Stamford,
Connecticut
|
-$7.04M |